l9n/ Connecticut

2010 Regular Session

Senate Bill 254

AN ACT CONCERNING DISCLOSURE OF MAXIMUM ALLOWABLE COSTS FOR PHARMACY REIMBURSEMENTS.

Did not become law. It stopped in the House of Representatives on May 4, 2010. The 2010 session has ended.

What it does

The synopsis the General Assembly published with the bill.

To require pharmacy benefit managers to disclose to health benefit plans such managers administer, the maximum allowable costs to be paid for generic prescription drugs under such plans.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Joan V. Hartley

In the House of Representatives

    1 co-sponsor

    T.R. Rowe

    Its course

    February 23 to May 4, 2010, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

    Each committee stop sits inside its chamber.

    Every action23 actions on 10 days

    In the SenateFeb 23 to May 470 days

    Judiciary CommitteeApr 14 to Apr 206 days

    In the House of RepresentativesMay 4 to May 4 · stopped0 days

    Amendments

    Each amendment offered, and what became of it.

    • Senate floor amendmentAdopted

      Adopted May 4

    Text

    Each version as the General Assembly printed it.

    l9n doesn't hold this bill's text yet.

    What happened

    In l9n's words, one line for each step. Every action as the General Assembly published it is below.

    In the Senate Feb 23 – May 4

    1. Introduced and sent to Insurance and Real Estate Committee
    2. Heard in Insurance and Real Estate Committee
    3. Insurance and Real Estate Committee recommended a substitute for it
    4. Sent to Judiciary Committee
    5. Judiciary Committee recommended a substitute for it
    6. The Senate adopted Senate Amendment A
    7. Passed the Senate with Senate Amendment A

    In the House of Representatives May 4

    1. Sent to the House of Representatives
    All 23 actions, as published